MoonLake Immunotherapeutics
MLTX53
$52.67arrow_drop_up1.07%$0.56
MLTX53
$52.67
arrow_drop_up1.07%| Key Stats | |
|---|---|
| Open | $52.35 |
| Prev. Close | $52.14 |
| EPS | -1.27 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 51.25 | 53.42 |
| 52 Week Range | 35.11 | 64.98 |
| Ratios | |
|---|---|
| Revenue | - |
| EBITDA Margin % | - |
| EPS | -1.27 |
| Fundamentals | |
|---|---|
| Gross Profit | - |
| Payout Ratio | - |
| Industry average yield | 2.90% |
| Last Dividend pay date | - |
| Dividend per share | - |
| Dividend yield forecast | - |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
MLTX-
US Healthcare Sector-
US Market-
check_circle
MLTX / Market
MLTX exceeded the US Market which returned 1.00% over the last twenty four hours.warning
MLTX / Healthcare Sector
MLTX lose to the US Healthcare sector which returned 2.95% over the last twenty four hours.MoonLake Immunotherapeutics (MLTX) Statistics
Keep an eye on MoonLake Immunotherapeutics
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
How has MoonLake Immunotherapeutics (MLTX) stock's performance compared to its sector and the market over the past year?
Over the past year, MoonLake Immunotherapeutics (MLTX) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 25.34%, MoonLake Immunotherapeutics has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 47.67%, it has fallen short of the market average. This comparison highlights MoonLake Immunotherapeutics's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of MoonLake Immunotherapeutics (MLTX) stock?
The PE ratio for MoonLake Immunotherapeutics (MLTX) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help
What is the EPS of MoonLake Immunotherapeutics (MLTX) stock?
The Earnings Per Share (EPS) for MoonLake Immunotherapeutics (MLTX), calculated on a diluted basis, is -$1.27. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of MoonLake Immunotherapeutics (MLTX) stock?
The operating margin for MoonLake Immunotherapeutics (MLTX) is 0%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help
What is the EBITDA of MoonLake Immunotherapeutics (MLTX) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of MoonLake Immunotherapeutics (MLTX) is -$108.45M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How much debt does MoonLake Immunotherapeutics (MLTX) have?
MoonLake Immunotherapeutics (MLTX) has a total debt of $3.38M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$371.97M.